曲美他嗪对心肌缺血大鼠运动耐量的影响研究(3)
[3] 衣紹蕊，孙经武，张明哲，等.曲美他嗪对慢性心力衰竭患者血管内皮功能的影响研究[J].中国全科医学，2014，17(20)：2321-2324.
[4] Rossoni LV， Oliveira RA， Caffaro RR， et al. Cardiac benefits of exercise training in aging spontaneously hypertensive rats[J]. J Hypertens， 2011， 29(12)：2349-2358.
[5] Jia LL， Kang YM， Wang FX， et al. Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus[J] . PLoS One，2014， 9(1)： e85481.
[6] Ghadieh AS， Saab B. Evidence for exercise training in the management of hypertension in adults[J]. Can Fam Physician，2015， 61(3)： 233-239.
[7] Fagard RH. Exercise therapy in hypertensive cardiovascular disease[J]. Prog Cardiovasc Dis， 2011， 53(6)：404-411.
[8] Lee DC， Pate RR， Lavie CJ， et al. Leisure-time running reduces all-cause and cardiovascular mortality risk[J]. JACC， 2014， 64(5)：472-481.
[9] Levine AB， Punihaole D， Levine TB. Characterization of the role of nitric oxide and its clinical applications[J].Cardiology，2012，122( 1)：55-68.
[10] Kantor PF， Lucien A， Kozak R， et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3ketoacyl coenzyme A thiolase [J]. Circ Res，2000，86(5)：580-588.
(收稿日期：2017-09-15), http://www.100md.com(张奕)
[4] Rossoni LV， Oliveira RA， Caffaro RR， et al. Cardiac benefits of exercise training in aging spontaneously hypertensive rats[J]. J Hypertens， 2011， 29(12)：2349-2358.
[5] Jia LL， Kang YM， Wang FX， et al. Exercise training attenuates hypertension and cardiac hypertrophy by modulating neurotransmitters and cytokines in hypothalamic paraventricular nucleus[J] . PLoS One，2014， 9(1)： e85481.
[6] Ghadieh AS， Saab B. Evidence for exercise training in the management of hypertension in adults[J]. Can Fam Physician，2015， 61(3)： 233-239.
[7] Fagard RH. Exercise therapy in hypertensive cardiovascular disease[J]. Prog Cardiovasc Dis， 2011， 53(6)：404-411.
[8] Lee DC， Pate RR， Lavie CJ， et al. Leisure-time running reduces all-cause and cardiovascular mortality risk[J]. JACC， 2014， 64(5)：472-481.
[9] Levine AB， Punihaole D， Levine TB. Characterization of the role of nitric oxide and its clinical applications[J].Cardiology，2012，122( 1)：55-68.
[10] Kantor PF， Lucien A， Kozak R， et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3ketoacyl coenzyme A thiolase [J]. Circ Res，2000，86(5)：580-588.
(收稿日期：2017-09-15), http://www.100md.com(张奕)